Clearbridge Investments, LLC Glaukos Corp Transaction History

Clearbridge Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$25.53 - $70.14 $20.6 Million - $56.5 Million	-805,377 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $5.04 Million - $6.11 Million	93,047 Added 13.06%	805,377 $43.8 Million
Q3 2019 Nov 14, 2019	BUY	$58.58 - $83.91 $27.2 Million - $39 Million	464,715 Added 187.68%	712,330 $44.5 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $15.7 Million - $19.5 Million	247,615 New	247,615 $0

345

46.7M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.